AGF Management’s Medtronic MDT Stock Holding History

AGF Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$345K	Sell	3,983 -47	-1%	-$4.5K	﹤0.01%	614
2025 Q4	$387K	Sell	4,030 -95	-2%	-$9.23K	﹤0.01%	614
2025 Q3	$393K	Sell	4,125 -138	-3%	-$12.7K	﹤0.01%	616
2025 Q2	$372K	Buy	4,263 +24	+0.6%	+$2.04K	﹤0.01%	603
2025 Q1	$381K	Buy	4,239 +43	+1%	+$3.85K	﹤0.01%	624
2024 Q4	$335K	Buy	+4,196	New	+$363K	﹤0.01%	662
2024 Q3	–	Sell	-3,529	Closed	-$278K	–	700
2024 Q2	$278K	Sell	3,529 -15,624	-82%	-$1.28M	﹤0.01%	663
2024 Q1	$1.67M	Buy	19,153 +9,180	+92%	+$783K	0.01%	514
2023 Q4	$822K	Buy	+9,973	New	+$760K	﹤0.01%	584
2023 Q3	–	Sell	-9,078	Closed	-$800K	–	754
2023 Q2	$800K	Buy	+9,078	New	+$782K	0.01%	569

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AGF Management's MDT Position: Q1 2026 in Review

AGF Management reduced its Medtronic (MDT) stake by 1.2% in Q1 2026, selling an estimated $4.5K and leaving 3,983 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

AGF Management first reported a position in MDT in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.67M in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

AGF Management held 3,983 shares of Medtronic worth $345K as of Q1 2026.
AGF Management sold 47 Medtronic shares in Q1 2026, an estimated $4.5K.
Medtronic made up ﹤0.01% of AGF Management's portfolio in Q1 2026, its #614 holding.
AGF Management first reported a position in Medtronic in Q2 2023 and has held it in 10 quarters since.
AGF Management's Medtronic position peaked at $1.67M in Q1 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.